期刊文献+

血清PSA值及直肠指检指导前列腺穿刺活检的临床意义 被引量:1

Clinical Effect Study of Serum PSA Level and Digital Rectal Examination in Guiding the Prostate Biopsy
下载PDF
导出
摘要 目的探讨血清PSA浓度及直肠指检在指导前列腺穿刺活检中的价值。方法对59例血清PSA>4ng/ml和(或)直肠指检前列腺有结节的患者,行经直肠B超引导下前列腺穿刺活检。结果59例患者中前列腺活检阳性者32例(54%),PSA浓度>10ng/ml组活检阳性率较PSA<10ng/ml组高(P<0.05)。直肠指检发现有结节的患者,前列腺活检阳性率较无结节明显增高(P<0.05)。结论随着血清PSA浓度升高,前列腺活检阳性率升高;对于直肠指检发现有结节患者,即使PSA<4ng/ml,也应行前列腺穿刺活检排除前列腺癌。 Objective To explore the serum prostate-specific antigen level and digital rectal examination in guiding the prostate biopsy. Methods Transrectal ultrasound-guided needle biopsy of prostate was performed by 59 patients with an elevated serum PSA(〉4.0ng/ml) and abnormal findings on rectal palpation. Results 32(54%)of the 59 were diagnosed as prostate cancer on biopsy. The positive rate of biopsy in PSA〉 10ng/ml group was higher than in PSA〈10ng/ml group(P〈0. 05). The positive rate of biopsy in abnormal nodus group was higher than in no nodus group (P〈0. 05)o Conclusions With the increasing serum prostatespecific antigen level, prostate biopsy had higher positive findings. Patient who have abnormal nodus in rectal palpation must perform prostate biopsy ,even in patient with PSA〈4ng/ml.
出处 《国际医药卫生导报》 2006年第23期32-33,共2页 International Medicine and Health Guidance News
关键词 PSA 直肠指检 前列腺 穿刺活检术 Prostate specific antigen Digital rectal examination Prostate biopsy
  • 相关文献

参考文献4

  • 1方友强,高新.生物标记物早期诊断前列腺癌的研究进展[J].新医学,2005,36(5):309-310. 被引量:3
  • 2Cooner WH ,Mosley BR ,Rutherford CL,et al. Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostatecancer. J Urol ,1988 ,139:758-761
  • 3Thomas A. Stamey, Mitcholl caldwell, John E. Mcneal,et al. The prostate spocific antigen era in the united states is over for prostate cancer:What happen inthe last 20 years?2004,172(10):1297-1301
  • 4Watson RW, Schalken JA. Future opportunities for the diagnosis and treatment of prostate cancer. Prostate Cancer Prostatic Dis, 2004, 7 (1):S8-S13

二级参考文献23

  • 1肖雨,陈杰,罗玉凤,曹金玲,凌庆,金锋.前列腺腺癌中P504S的检测及意义[J].中华医学杂志,2004,84(16):1362-1366. 被引量:16
  • 2Martel CL, Gumerlock PH, Meyers FJ, et al. Current strategies in the management of hormone refractory prostate cancer. Cancer Treat Rev,2003, 29 (3): 171-187.
  • 3Hessels D, Verhaegh GW, Schalken JA, et al. Applicability of biomarkers in the early diagnosis of prostate cancer. Expert Rev Mol Diagn, 2004, 4 (4): 513-526.
  • 4Graner LS, Lawler KD, Marignca JL, et al. Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM'protein in the LNCaP prostatic carcinoma cell line. Cancer Res, 1998, 58(21): 4787-4789.
  • 5Basso D, Fogar MG, Piva MG, et al. Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: which is clinically effective and when? Urology, 2000, 55 (5): 710-715.
  • 6Chu DC, Chuang CK, Liou YF, et al. The use of real-time quantitative PCR to detect circulating prostate-specific membrane antigen mRNA in patients with prostate carcinoma. Ann N Y Acad Sci, 2004, 1022 (4):157-162.
  • 7Nam RK, Dianeondis EP, Toi A, et al. Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen. J Clin Oncol, 2000, 18 (5):1036-1042.
  • 8Magklara A, Scorilas A, Catalona WJ, et al. The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic byperplasia in patients with moderately increased total PSA. Clin Cbem, 1999, 45 ( 11 ) :1961-1966.
  • 9Kwiatkowski MK, Recker F, Piiromen T, et al. In prdstatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA4 to 10 ng/mL Urology, 1998, 52 (3) : 360-365.
  • 10Vaisanen V, Efikssen S, Ivaska KK, et al. Development of sensitive immunoassays for free and total human glandular kalfikrein 2. Clin Chem,2004, 50 (9): 1607-1617.

共引文献2

同被引文献9

  • 1全国肿瘤防治研究办公室,全国肿瘤登记中心,卫生部疾病预防控制局.中国肿瘤登记年报2004[M].北京:中国协和医科大学出版社.2008.16-28.
  • 2Jemal A, Bray F, Center MM, el al. Global cancer statistics[J].CA Cancer J Clin, 2011, 61 (2): 69-90.
  • 3Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics, 2001[J].CA CancerJ Clin, 2001, 51(1): 15-36.
  • 4Catalona WJ, Richie JP, Ahmann FR, et el. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter elinical trial of 6,630 men[J].J Urol, 1994, 151(5): 1283-1290.
  • 5Hodge KK, McNeal JE, Terris MK, et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate[J].J Urol, 1989, 142(1): 71-75.
  • 6Singh H, Canto EI, Shariat SF, et al. Improved detection nf clinically significant, curable prostate cancer with systematic 12--core biopsy[J].J Urol, 2004, 171(3): 1089--1092.
  • 7谢群,褚靖,朱文燕,杨信,曹明奎,陈世清,张恒.改良式经直肠前列腺8点穿刺术在前列腺癌诊断中的应用[J].现代泌尿生殖肿瘤杂志,2011,3(2):69-71. 被引量:5
  • 8王友志,郝斌,许长宝,郭瑞宾.超声引导下经直肠系统性12+1针前列腺穿刺活检术[J].现代泌尿生殖肿瘤杂志,2013,5(2):84-86. 被引量:4
  • 9陈新,李伟,刘津灵.5区13针与4区10针前列腺穿刺活检诊断前列腺癌的临床对比研究[J].现代中西医结合杂志,2013,22(24):2653-2654. 被引量:8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部